| Publications |
(Currently 512486 Items)
|
 |
| Partners |
|
|
|
| BIOTECHNOLOGY / Total: 9100 |
PREVIOUS | 6
| 7
| 8
| 9
| 10
| 11
| 12
| 13
| 14
| 15
| 16
| 17
| 18
|
NEXT 
|
| Title |
Date |
Price |
|
The Quidel Corporation Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Oct, 2006 |
€375 |
|
The Quigley Corporation The Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Quinton Cardiology Systems Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Oct, 2006 |
€375 |
|
The Regen Therapeutics plc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
This brief discusses trends among both the consumer and physician populations in the UK, as well as an exploration of the government''s changing policies regarding the use of technology in healthcare.... |
Mar, 2002 |
€2 033 |
|
The global antivirals market is forecast to grow from $8.7bn in 2001 to $14bn in 2007, largely due to the high incidence of viral infections and the inadequate efficacy of the drugs currently available.... |
Mar, 2003 |
€3 076 |
|
The Regeneration Technologies Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Oct, 2006 |
€375 |
|
The Regeneron Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The RegeneRx Biopharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Renovis Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Repligen Corporation Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Rigel Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Roche Holdings Ltd Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Salix Pharmaceuticals Ltd Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Samaritan Pharmaceuticals Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed... |
Jan, 2007 |
€375 |
|
The Sangamo BioSciences Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
If you've been looking for a source for independent and insightful research that speak plain English, look no more. Each month the Wong's BioTech Stock Report provides a fresh, intuitive, inside look... |
Dec, 2005 |
€234 |
|
The Sanguine Corp Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
The Sanofi-Synthelabo S A Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Jan, 2007 |
€375 |
|
The Santarus Inc Competitor Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication... |
Jan, 2007 |
€375 |
|
|
|
|
